Characterization of the novel HLA-DPB1*02:01:63 allele by sequencing-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
10 2022
Historique:
received: 01 06 2022
accepted: 07 06 2022
pubmed: 11 6 2022
medline: 17 9 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

HLA-DPB1*02:01:63 differs from HLA-DPB1*02:01:02:04 by one nucleotide substitution in codon 144 in exon 3.

Identifiants

pubmed: 35681276
doi: 10.1111/tan.14703
doi:

Substances chimiques

HLA-DP beta-Chains 0
HLA-DPB1 antigen 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-408

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Cargou M, Ralazamahaleo M, Blouin L, et al. Evaluation of the AllType kit for HLA typing using the ion torrent S5 XL platform. HLA. 2020;95(1):30-39. doi:10.1111/tan.13708
Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48(D1):D948-D955. doi:10.1093/nar/gkz950
Bouthemy C, Ralazamahaleo M, Jollet I, Filloux M, Visentin J, Guidicelli G. Improvement in HLA-typing by new sequence-specific oligonucleotides kits for HLA-A, -B and -DRB1 loci. HLA. 2018;92(5):279-287. doi:10.1111/tan.13382
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455. doi:10.1111/j.1399-0039.2010.01466.x

Auteurs

Marine Cargou (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Vincent Elsermans (V)

CHU de Lille, Institut d'Immunologie-HLA, Lille, France.

Isabelle Top (I)

CHU de Lille, Institut d'Immunologie-HLA, Lille, France.

Mamy Ralazamahaleo (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
Univ. Bordeaux, CNRS, Bordeaux, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH